Your Health, We Care
Sotorasib is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
from FDA，2023.04
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA···【more】
Release date：2026-03-23Recommended：48
On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration ···【more】
Release date：2026-03-23Recommended：54
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls unde···【more】
Release date：2024-08-05Recommended：278
Sotorasib, a novel small molecule targeted therapeutic agent, presents a promisi···【more】
Release date：2024-08-05Recommended：357
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls unde···【more】
Release date：2024-07-09Recommended：369
